Clinical TrialsSearch results
Number of results: 506
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer disease (EVOKE)
- MCI or mild dementia of the Alzheimer type
- Nota Ayumi
- 2021-05-24
Recruiting
- Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer
- Limited Stage Small Cell Lung Cancer (LS-SCLC)
- Kagamu Hiroshi
- 2021-05-24
Other
- A phase 2 study of pembrolizumab in combination with olaparib in patients with cervical cancer previously treated with platinum-based chemotherapy
- recurrent or metastatic cervical cancer
- Hasegawa Kosei
- 2021-05-18
Other
- A 26-week trial comparing the effect and safety of once weekly insulin icodec and once daily insulin glargine 100 units/mL, both in combination with bolus insulin with or without non-insulin anti-diabetic drugs, in subjects with type 2 diabetes on a basal-bolus regimen.(NN1436-4480)
- type 2 diabetes
- Nishida Hiroko
- 2021-05-10
Recruiting
- A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants with Atypical Hemolytic Uremic Syndrome (aHUS)
- Atypical Hemolytic Uremic Syndrome
- Camelia Sima
- 2021-04-27
Other
- WP-2011
- Cataract
- Ichikawa Kazuo
- 2021-04-12
Other
- Efficacy and safety of once weekly insulin icodec compared to once daily insulin degludec 100 units/mL, both in combination with insulin aspart, in adults with type 1 diabetes.
- type 1 diabetes
- Oyatani Akihito
- 2021-04-09
Recruiting
- A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy.
- ctDNA positive high risk MIBC
- Hajer Lassidi
- 2021-04-06
Other
- A Phase 3 Study of Lenvatinib Plus Pembrolizumab in Previously Treated Participants with Metastatic Colorectal Cancer (LEAP-017)
- unresectable non MSIH/dMMR mCRC
- Shimoyama Ryo
- 2021-03-31